Clinical Takeaway This issue examines a convergence of compelling evidence across metabolic medicine, with new research strengthening the case for GLP-1 receptor agonists in liver disease management, weight loss optimization, and diabetes...
GLP-1 Receptor Agonist Shows Liver Benefits in New Research
GLP-1 Clinical Relevance #45Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News | CED Clinic NewsObservational StudyMetabolic Liver DiseaseSemaglutideEndocrinologyPreclinical Mouse ModelHepatic OutcomesGLP-1 Receptor AgonistNovo NordiskNonalcoholic Fatty Liver...
Two compounds found in cannabis plant reverse liver disease damage, study suggests
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic HepatologyPreclinical ResearchAnti-InflammatoryFibrosisDrug Development Why This MattersLiver disease represents a significant morbidity burden where...
Two compounds found in cannabis plant reverse liver disease damage, study suggests
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchCBDTHCAging Why This Matters This study identifying specific cannabis compounds that may reverse liver disease...
Cannabis compounds reverse fatty liver disease in mice – Instagram
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Liver DiseasePreclinical ResearchMetabolismNafldEndocannabinoid System Why This MattersPreclinical studies on cannabinoids and metabolic liver disease...
Two compounds found in surprising substance reverse liver disease damage, study suggests
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Liver DiseaseCbdCbgPreclinical ResearchMasld Why This MattersThis represents early preclinical evidence for cannabinoids in...
Two compounds found in cannabis plant reverse liver disease damage, study suggests
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Liver DiseaseAnti-InflammatoryNashHepatotoxicityPreclinical Research Why This MattersLiver disease affects millions globally with limited therapeutic...
Therapeutic potential of cannabidiol supplementation in mitigating lipid precursors of inflammation in hepatic steatosis progression.
This study investigated the effects of cannabidiol (CBD) on early-stage inflammation, a key factor in the progression of liver diseases from metabolic dysfun…
CBD And CBG From The Cannabis Plant Could Help Treat A Common Liver Condition | IFLScience
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Liver DiseaseCbdCbgPreclinical ResearchNafld Why This MattersNon-alcoholic fatty liver disease affects nearly 25% of US...
Targeting the LPI/GPR55 Axis in MAFLD and MASH: Novel Insights, Therapeutic Strategies and Future Directions.
Metabolic dysfunction-associated fatty liver disease (MAFLD), recently redefined from non-alcoholic fatty liver disease (NAFLD), highlights the central role …